Jason Chew Vivus shares tanked after an expert panel voted 10 to 6 against approving its obesity drug, Qnexa. The panel was particularly worried that Vivus only had one year data for its drug- not long enough in its opinion to gather long term safey data in light of Qnexa’s CNS and Cardiovascular side effects. Qnexa […]
Why Arena’s Lorcaserin Will Not Be Used In Combination With Phentermine
Jason Chew It is tempting to believe that once Lorcaserin has been approved, it will be used off-label in combination with phentermine to create a safe and efficacious version of Fen-Phen, the once popular diet drug. This is not to be the case. Some history:Fenfluramine, the “Fen” in Fen-Phen, a potent agonist of 5-HT2B receptors, […]
